Nikki Votaw is an Associate Director at Isolere Bio with her work focused on addressing critical challenges in the production of advanced therapeutics, particularly for the applications of cell and gene therapy. She has dedicated several years to pioneering the development of cutting-edge protein reagents designed to optimize and enhance the manufacturing processes involved in these revolutionary therapies. The products stemming from her work have the potential to create a paradigm shift in downstream processing platforms for viral vectors in addition to profound societal impact by making curative treatments more accessible globally. Nikki is an author on multiple patents and publications stemming from both academic and industry research. She completed her BS in Biomedical Engineering at Georgia Tech and her PhD in Biomedical Engineering at Duke University.